Literature DB >> 30476946

Comparison of Optical Coherence Tomography With Fundus Photographs, Fluorescein Angiography, and Histopathologic Analysis in Assessing Coats Disease.

Sally S Ong1,2, Thomas J Cummings3, Lejla Vajzovic2, Prithvi Mruthyunjaya4, Cynthia A Toth2.   

Abstract

Importance: Coats disease is a rare pediatric vitreoretinopathy that can cause devastating visual and anatomic outcomes. Objective: To compare optical coherence tomography (OCT) with fundus photographs, fluorescein angiography (FA), and histopathologic findings in Coats disease. Design, Setting, and Participants: This retrospective cohort study was conducted in a single tertiary institution (Duke Eye Center) and identified 28 children with Coats disease through a review of medical records from December 2002 to January 2018. Four eyes were obtained from a biorepository for histopathologic analysis. Main Outcomes and Measures: Macular OCT, fundus photographs, and FA results were reviewed and compared for morphological changes. These were compared with retinal histopathological findings.
Results: The mean (SD) age was 9.5 (5.5) years for the 28 children (and 29 eyes) with clinical imaging results, and 24 (86%) were boys. A comparison between imaging modalities revealed OCT features that were not visible in photographs or FA, including exudates in multiple retinal layers (23 [82.1%]), small pockets of subretinal fluid (4 [14.3%]), an outer retinal atrophy overlying fibrotic nodules (7 [25.0%]), and small preretinal hyperreflective OCT dots (25 [89.3%]). Next, a comparison with light micrographs introduced an association of OCT findings with possible pathological features, including hyperreflective linear structures on OCT that appeared consistent with cholesterol crystals, small hyperreflective dots with macrophages, outer retinal tubulations with rosettes, and analogous OCT histopathology features such as intraretinal vessels entering fibrotic nodules and retinal pigment epithelium excrescences under the subretinal fluid. An OCT analysis revealed intraretinal cystoid spaces in 19 eyes, but in 9 of 19 (47.4) this was not associated with cystoid macular leakage; rather, fluorescein leakage was observed from peripheral telangiectatic vessels. Additionally, exudates were intraretinal only (6 [21.4%]) or both intraretinal and subretinal (17 [60.7%]); none were subretinal only. In eyes with follow-up results, new fibrosis developed in 8 of 17 eyes (47.1%). Fibrosis developed in 5 of 5 eyes (100%) with baseline subretinal fluid vs 3 of 12 without (25%; 95% CI, 22%-92%) and in 7 of 9 eyes (77.8%) with subretinal exudates vs 1 of 8 (12.5%) without (95% CI, 16%-89%). Conclusions and Relevance: Optical coherence tomography may show the transient and permanent effects of Coats disease on the retina. These results suggest that exudates and fluid in the macular subretinal space appear later in the disease and may result in fibrosis formation. Further studies are needed to confirm if early treatment could prevent vision-threatening macular fibrosis.

Entities:  

Mesh:

Year:  2019        PMID: 30476946      PMCID: PMC6439851          DOI: 10.1001/jamaophthalmol.2018.5654

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


  25 in total

1.  Intraoperative spectral-domain optical coherence tomography in coats' disease.

Authors:  Christopher R Henry; Audina M Berrocal; Ditte J Hess; Timothy G Murray
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2012-07-26

2.  Intraoperative fluorescein angiography-guided treatment in children with early Coats' disease.

Authors:  Martina Suzani; Anthony T Moore
Journal:  Ophthalmology       Date:  2015-03-29       Impact factor: 12.079

3.  The exaggerated macular response to retinal disease.

Authors:  G N Wise; Y Wangvivat
Journal:  Am J Ophthalmol       Date:  1966-05       Impact factor: 5.258

4.  Coats's disease: definition and pathogenesis.

Authors:  W A Manschot; W C de Bruijn
Journal:  Br J Ophthalmol       Date:  1967-03       Impact factor: 4.638

5.  Bilateral fluorescein angiographic findings in unilateral Coats' disease.

Authors:  Thomas S Shane; Audina M Berrocal; Ditte J Hess
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2011-02-10

6.  Serous macular detachment secondary to distant retinal vascular disorders.

Authors:  Tomohiro Otani; Yumiko Yamaguchi; Shoji Kishi
Journal:  Retina       Date:  2004-10       Impact factor: 4.256

7.  Fundus autofluorescence and central serous chorioretinopathy.

Authors:  Richard F Spaide; James M Klancnik
Journal:  Ophthalmology       Date:  2005-05       Impact factor: 12.079

8.  Macular fibrosis in Coats disease.

Authors:  J Michael Jumper; Dustin Pomerleau; H Richard McDonald; Robert N Johnson; Arthur D Fu; Emmett T Cunningham
Journal:  Retina       Date:  2010-04       Impact factor: 4.256

9.  Retinal angiomatous proliferation with chorioretinal anastomosis in childhood Coats disease: a reappraisal of macular fibrosis using multimodal imaging.

Authors:  Eric J Sigler; Jorge I Calzada
Journal:  Retina       Date:  2015-03       Impact factor: 4.256

10.  Peripheral retinal nonperfusion in fellow eyes in coats disease.

Authors:  Michael P Blair; J Niklas Ulrich; M Elizabeth Hartnett; Michael J Shapiro
Journal:  Retina       Date:  2013-09       Impact factor: 4.256

View more
  3 in total

1.  Linear and planar reflection artifacts on swept-source and spectral-domain optical coherence tomography due to hyperreflective crystalline deposits.

Authors:  Serena Fragiotta; Pedro Fernández-Avellaneda; Mark P Breazzano; Lawrence A Yannuzzi; Christine A Curcio; K Bailey Freund
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-12-26       Impact factor: 3.117

2.  Commentary: Hyperreflective dots - An imaging biomarker of inflammation?

Authors:  Aniruddha Agarwal
Journal:  Indian J Ophthalmol       Date:  2019-11       Impact factor: 1.848

3.  Clinical Features and Surgical Treatment of Subretinal Proliferation in Proliferative Diabetic Retinopathy.

Authors:  Chan Wu; Rongping Dai; Youxin Chen; Xiao Zhang; Zhe Chen
Journal:  Front Med (Lausanne)       Date:  2022-02-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.